<DOC>
	<DOCNO>NCT00773058</DOCNO>
	<brief_summary>The purpose study see stress dos hydrocortisone improve early outcome patient early stage ARDS relative adrenal insufficiency .</brief_summary>
	<brief_title>Effect Treatment With Stress-Doses Glucocorticoid Patients With Acute Respiratory Distress Syndrome ( ARDS )</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Respiratory Distress Syndrome , Newborn</mesh_term>
	<mesh_term>Respiratory Distress Syndrome , Adult</mesh_term>
	<mesh_term>Acute Lung Injury</mesh_term>
	<mesh_term>Adrenal Insufficiency</mesh_term>
	<mesh_term>Glucocorticoids</mesh_term>
	<mesh_term>Hydrocortisone 17-butyrate 21-propionate</mesh_term>
	<mesh_term>Cortisol succinate</mesh_term>
	<mesh_term>Hydrocortisone acetate</mesh_term>
	<mesh_term>Hydrocortisone</mesh_term>
	<criteria>within first 3 day onset clinically definite ARDS confirm AECC criterion 1994 18 85 year old pregnancy lactation tumor immunologic disease immunosuppressive drug use bone marrow lung transplantation primary secondary disease adrenal gland hormone use within 3 month refuse conventional therapy clinical test within 30 day</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>January 2009</verification_date>
	<keyword>acute respiratory distress syndrome</keyword>
	<keyword>glucocorticoid</keyword>
	<keyword>adrenal insufficiency</keyword>
</DOC>